AIM: To study individualized treatment of malignant glaucoma.

METHODS: Totally 19 malignant glaucoma patients(19 eyes)admitted in Leshan Ophthalmological Center from January 2016 to October 2018 were retrospectively analyzed. Main outcomes of best corrected visual acuitv, intraocular pressure(IOP), anterior chamber depth and complications were closely observed.

RESULTS: IOP were recovered by drug treatments in 7 eyes to anterior chamber depth. 3 eyes were treated by peripheral iridectomy combined with posterior capsule of lens and anterior vitreous membrane excision with YAG laser. 5 eyes were treated by cataract phacoemulsification with foldable intraocular lens implantation combined with posterior capsule excision and anterior vitrectomy. 1 eye was treated by vitrectomy.1 eye developed to malignant glaucoma during operation was treated by trabeculectomy combined with cataract phacoemulsification after vitreous water-bag was punctured. The post-treatment IOP(14.43±3.46mmHg)significantly declined compared with pre-treatment IOP(31.25±5.19mmHg), the post-treatment anterior chamber depth(2.64±0.47mm)significantly deepened compared with that of pre-treatment(0.69±0.57mm). The best corrected visual acuity in LogMAR before treatment was 0.71±0.25, after the treatment of 0.34±0.19(P<0.05). There were no serious complications except 1 case with low intraocular pressure and choroidal detachment.

CONCLUSION: It is necessary to fully evaluate the specific conditions of patients after the occurrence of malignant glaucoma and adopt individualized treatments according to patient's condition.